Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy

Abstract

These results suggest that PFD induces PARK2-mediated mitophagy and also inhibits lung fibrosis development in the setting of insufficient mitophagy, which may at least partly explain the anti-fibrotic mechanisms of PFD for IPF treatment.